Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

Summary

The study will evaluate the effect of NTRA-2112 on intestinal malabsorption in preterm infants.

Timeline

Start

2016-10-09

Primary completion

2018-04-25

Completion

2018-04-25

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Publications

• Mank E, Saenz de Pipaon M, Lapillonne A, Carnielli VP, Senterre T, Shamir R, van Toledo L, van Goudoever JB; FIT-04 Study Group. Efficacy and Safety of Enteral Recombinant Human Insulin in Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr. 2022 May 1;176(5):452-460. doi: 10.1001/jamapediatrics.2022.0020.

Drugs

Indications